Lahdes K, Kaila T, Huupponen R, Salminen L, Iisalo E
Department of Pharmacology, University of Turku, Finland.
Clin Pharmacol Ther. 1988 Sep;44(3):310-4. doi: 10.1038/clpt.1988.155.
We quantitated atropine plasma levels and monitored blood pressure, heart rate, and salivary secretion after ocular application. Eight patients received 40 microliters 1% atropine in the lower cul-de-sac of one eye in connection with ocular surgery. Atropine plasma levels were determined for 90 minutes by radioreceptor assay. The peak plasma atropine concentration of 860 +/- 402 pg/ml was reached within 8 minutes in all patients. The ocular absorption of atropine was at least as rapid as that reported for intramuscular administration. Ocular atropine did not affect patients' blood pressure or heart rate when compared with those of the placebo group. Thirty minutes after administration of atropine eyedrops, the salivary secretion in the experimental group was reduced, but was statistically insignificant from the placebo group.
我们测定了眼用阿托品后的血浆水平,并监测了血压、心率和唾液分泌。8例患者在眼科手术时于一眼的下穹窿部接受了40微升1%阿托品。通过放射受体分析法测定90分钟内的阿托品血浆水平。所有患者均在8分钟内达到了860±402 pg/ml的血浆阿托品浓度峰值。阿托品的眼部吸收至少与肌内注射的报告速度一样快。与安慰剂组相比,眼用阿托品对患者的血压或心率没有影响。滴注阿托品眼药水30分钟后,实验组的唾液分泌减少,但与安慰剂组相比无统计学意义。